Key points are not available for this paper at this time.
VHD trials have expanded in scale and scope with increased trial-level mean age. However, persistent sex disparities and demographic variability highlight the need for more inclusive trial designs to guide equitable valve therapy.
Rivera et al. (2025) studied this question.